P D Sander Dijkstra
Overview
Explore the profile of P D Sander Dijkstra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1196
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verschoor A, Speetjens F, Dijkstra P, Fiocco M, van de Sande M, Bovee J, et al.
Oncologist
. 2020 Apr;
25(4):e716-e721.
PMID: 32297446
Background: The effectiveness of second-line palliative chemotherapy in patients with recurrent/metastatic osteosarcoma is not well defined. Several small studies (6-19 patients) have reported on ifosfamide as second-line treatment. In this...
2.
van der Bruggen W, Hagelstein-Rotman M, de Geus-Oei L, Smit F, Dijkstra P, Appelman-Dijkstra N, et al.
Eur J Nucl Med Mol Imaging
. 2019 Dec;
47(6):1527-1537.
PMID: 31875244
Purpose: To quantify NaF-PET/CT uptake in relation to clinical and biochemical parameters of fibrous dysplasia (FD) severity and healthy bone (HB) metabolism. Secondary aims: comparing normalization for volume of distribution...
3.
Andreou D, Ranft A, Gosheger G, Timmermann B, Ladenstein R, Hartmann W, et al.
Clin Orthop Relat Res
. 2019 Oct;
478(2):290-302.
PMID: 31580267
Background: Local treatment of pelvic Ewing's sarcoma may be challenging, and intergroup studies have focused on improving systemic treatments rather than prospectively evaluating aspects of local tumor control. The Euro-EWING99...
4.
Majoor B, Papapoulos S, Dijkstra P, Fiocco M, Hamdy N, Appelman-Dijkstra N
J Clin Endocrinol Metab
. 2019 Aug;
104(12):6069-6078.
PMID: 31390018
Context: Fibrous dysplasia/McCune-Albright syndrome (FD/MAS) is a rare bone disorder commonly treated with bisphosphonates, but clinical and biochemical responses may be incomplete. Objective: To evaluate the efficacy and tolerability of...
5.
van de Sande M, van der Wal R, Navas Canete A, van Rijswijk C, Kroon H, Dijkstra P, et al.
Cancer
. 2019 Aug;
125(19):3288-3291.
PMID: 31381137
No abstract available.
6.
Bosma S, Cleven A, Dijkstra P
Clin Orthop Relat Res
. 2019 May;
477(7):1548-1559.
PMID: 31107331
Background: Anatomic and surgical complexity make pelvic and sacral bone sarcoma resections challenging. Positive surgical margins are more likely to occur in patients with pelvic and sacral bone sarcomas than...
7.
Majoor B, Traunmueller E, Maurer-Ertl W, Appelman-Dijkstra N, Fink A, Liegl B, et al.
Acta Orthop
. 2019 May;
90(4):401-405.
PMID: 31035847
Background and purpose - Fibrous dysplasia (FD) is a rare bone disorder associated with pain, deformities, and pathological fractures. The pathophysiological mechanism of FD-related pain remains ill-understood. We evaluated the...
8.
Willeumier J, Kaynak M, van der Zwaal P, Meylaerts S, Mathijssen N, Jutte P, et al.
Clin Orthop Relat Res
. 2018 Dec;
476(9):1823-1833.
PMID: 30566108
Background: Actual and impending pathologic fractures of the femur are commonly treated with intramedullary nails because they provide immediate stabilization with a minimally invasive procedure and enable direct weightbearing. However,...
9.
Willeumier J, van der Wal C, Schoones J, van der Wal R, Dijkstra P
J Surg Oncol
. 2018 Oct;
118(6):883-890.
PMID: 30328621
Pathologic fractures of the distal femur caused by bone metastases are not as common as those in the proximal femur but provide great difficulty to adequately treat. This systematic review...
10.
Verschoor A, Bovee J, Mastboom M, Dijkstra P, van de Sande M, Gelderblom H
Acta Orthop
. 2018 Jul;
89(5):570-574.
PMID: 29987945
Background and purpose - Giant cell tumors of bone (GCT-B) are rare, locally aggressive tumors characterized by an abundance of giant cells. Incidence studies for GCT-B are rare. This is...